Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxalyl-CoA decarboxylase (OXC) is a thiamin diphosphate (TPP)-dependent enzyme that catalyzes the decarboxylation of oxalyl-CoA to form formyl-CoA and carbon dioxide. This enzyme plays a critical role in oxalate metabolism, particularly in bacteria like *Oxalobacter formigenes*, and has therapeutic potential for treating hyperoxaluric conditions.
Enzymatic degradation of oxalyl-CoA to formyl-CoA and carbon dioxide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxalyl-CoA decarboxylase.